Literature DB >> 7824057

Endogenous inhibitors of human choline acetyltransferase present in Alzheimer's brain: preliminary observation.

I Singh1, C Xu, J W Pettegrew, J N Kanfer.   

Abstract

We have previously demonstrated the presence in Alzheimer's disease brain of an endogenous inhibitor of choline acetyltransferase activity. Selected properties of these compounds were investigated. There appear to be two distinct classes of inhibitor present, both phosphomonoesters and nonphosphorylated substances. They are not proteins, pass through 500 mm dialyses membranes and are not lipoidal. There are both different sensitivities of individual control cytosotic activity to inhibition and differences in intrinsic inhibitory activity present in individual Alzheimer's disease brain samples. There is a competitive type of inhibition with respect to acetyl CoA as substrate and a noncompetitive type with respect to choline as substrate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824057     DOI: 10.1016/0197-4580(94)00059-x

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  2 in total

Review 1.  Functional regulation of choline acetyltransferase by phosphorylation.

Authors:  Tomas Dobransky; R Jane Rylett
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.

Authors:  Swetha Vijayaraghavan; Azadeh Karami; Shahin Aeinehband; Homira Behbahani; Alf Grandien; Bo Nilsson; Kristina N Ekdahl; Rickard P F Lindblom; Fredrik Piehl; Taher Darreh-Shori
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.